Brugada electrocardiographic pattern due to tricyclic antidepressant overdose
Mateen Akhtar1, Nora F Goldschlager
1Division of Cardiology, San Francisco General Hospital, University of California at San Francisco Medical Center, San Francisco, CA 94143-0119, USA. makhtar@itsa.ucsf.edu
Abstract:
The Brugada syndrome is an arrhythmogenic disease with characteristic coved ST-segment elevation 2 mm or greater in the right precordial leads (type 1 Brugada electrocardiogram [ECG] pattern or "Brugada sign"] and is estimated to be responsible for at least 20% of sudden deaths in patients with structurally normal hearts [Circulation 2005;111(5):659-70]. The Brugada sign has been described in asymptomatic patients after exposure to various drugs. As published reports of the drug-induced Brugada sign have become increasingly prevalent, there is growing interest in the mechanisms responsible for this acquired ECG pattern and its clinical significance. We report a case of a patient who developed the type 1 Brugada ECG pattern after intentional overdose of a tricyclic antidepressant agent, review the literature concerning tricyclic antidepressant agent-induced Brugada sign, discuss potential mechanisms, and evaluate the clinical significance of this ECG abnormality.
More Related Videos
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Toxidromes: Clinical Features
Drugs Affecting Neurotransmitter Release or Uptake
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Antidepressant Drugs: MAOIs and Other Agents


